ACADIAN ASSET MANAGEMENT LLC - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIOXXXX and the CUSIP is 00211Y407. A total of 21 filers reported holding ARCA BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q1 2019$82,000
+60.8%
219,236
+42.8%
0.00%
Q4 2018$51,000
-32.9%
153,498
+12.6%
0.00%
Q3 2018$76,000
+35.7%
136,363
+35.9%
0.00%
Q2 2018$56,000
+12.0%
100,3360.0%0.00%
Q1 2018$50,000100,3360.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q1 2018
NameSharesValueWeighting ↓
Aveo Capital Partners, LLC 93,258$47,0000.02%
Tekla Capital Management LLC 811,227$405,0000.02%
Virtu Financial LLC 68,000$34,0000.00%
ROYCE & ASSOCIATES LP 326,147$163,0000.00%
BANK OF AMERICA CORP /DE/ 776$00.00%
NORTHERN TRUST CORP 14,074$7,0000.00%
MILLENNIUM MANAGEMENT LLC 11,124$6,0000.00%
DEUTSCHE BANK AG\ 352,030$175,0000.00%
CREDIT SUISSE AG/ 20,000$10,0000.00%
PANAGORA ASSET MANAGEMENT INC 88,994$44,0000.00%
View complete list of ARCA BIOPHARMA INC shareholders